首页 > 市场调查报告书 > 製药

感染疾病开发平台分析

市场调查报告书

商品编码

1741437

蚊媒感染疾病市场按疾病类型、治疗类型、最终用户和地区划分

Mosquito Borne Disease Market, By Disease Type, By Treatment Type, By End User, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

简介目录

蚊媒感染疾病市场规模预计在 2025 年为 35.8 亿美元，预计到 2032 年将达到 58.6 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 7.3%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	35.8亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	7.30%	2032年价值预测	58.6亿美元

蚊媒感染疾病是全球面临的重大公共卫生问题。这些疾病透过受感染蚊子的叮咬传播，威胁着人类生命，并造成沉重的疾病负担。驱蚊石板是应对蚊媒感染疾病的创新解决方案之一，它可以有效阻挡蚊虫，并降低疟疾、登革热和兹卡病毒等疾病的风险。

市场动态：

由于蚊媒感染疾病率的不断上升以及人们日益认识到其对公共健康的影响，预计全球蚊媒感染疾病市场在不久的将来将出现显着增长。政府和医疗保健组织正在大力投资研发有效的诊断和治疗方法。杀虫剂和捕蚊器等蚊虫控制方法的技术进步进一步促进了市场的成长。然而，也有一些挑战需要解决。市场成长的主要限制因素之一是缺乏意识和缺乏医疗设施，尤其是在新兴国家。医疗基础设施有限、资金不足和卫生条件差助长了蚊媒感染疾病的传播。此外，蚊子抗药性的产生和疫苗研发的复杂性也为市场带来了重大挑战。

儘管面临诸多挑战，全球蚊媒感染疾病市场仍蕴藏着巨大的机会。新型诊断工具、治疗药物和疫苗的开发带来了潜在的成长前景。此外，製药公司、研究机构和政府之间的合作与伙伴关係有望加速蚊虫控制和预防创新解决方案的开发。

本研究的主要特点

本报告对全球蚊媒感染疾病市场进行了详细分析，并以 2024 年为基准年，给出了预测期 2025-2032 的市场规模和年复合成长率（CAGR%）。
它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
根据公司亮点、产品系列、关键亮点、绩效和策略等参数，列出了全球蚊媒感染疾病市场的主要企业。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球蚊媒感染疾病市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过用于分析全球蚊媒感染疾病市场的各种策略矩阵来促进决策。

GlaxoSmithKline plc
Sanofi SA
Pfizer Inc.
Merck & Co., Inc.
Novartis AG
Johnson & Johnson
Eisai Co., Ltd
Takeda Pharmaceutical Company Limited
AstraZeneca
Valeant Pharmaceuticals International, Inc.
Mitsubishi Tanabe Pharma Corporation
Abbott
Hoffmann-La Roche Ltd
Sun Pharmaceutical Industries Ltd
Lupin Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
Serum Institute of India Pvt. Ltd.
CSL Limited
Teva Pharmaceutical Industries Ltd

第 10 章章节

调查方法
关于出版商

简介目录

Product Code: CMI6241

Mosquito Borne Disease Market is estimated to be valued at USD 3.58 Bn in 2025 and is expected to reach USD 5.86 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 3.58 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.30%	2032 Value Projection:	USD 5.86 Bn

Mosquito borne disease have been a significant public health concern in several parts of the world. These diseases, transmitted through the bite of infected mosquitoes, pose a threat to human lives, and are responsible for a considerable disease burden. One innovative solution to combat mosquito borne diseases is the development of a stone slab that repels mosquitoes, and thus, offering protection to individuals. This stone slab acts as an effective barrier against mosquitoes, reducing the risk of diseases such as malaria, dengue fever, and Zika virus.

Market Dynamics:

Global mosquito borne disease market is expected to witness significant growth in the near future due to increasing incidence of mosquito-borne diseases, coupled with growing awareness about their impact on public health. Governments and healthcare organizations are investing heavily in research and development to develop effective diagnostics and treatment options. Technological advancements in mosquito control methods such as insecticides and mosquito traps are further contributing to market growth. However, there are also several challenges that need to be addressed. One of the major restraints for the market growth is the lack of awareness and access to healthcare facilities, particularly in developing countries. Limited healthcare infrastructure, inadequate funding, and poor sanitation contribute to the spread of mosquito-borne diseases. Furthermore, the development of drug resistance in mosquitoes and the complexity of vaccine development pose significant challenges to the market.

Despite these challenges, there are significant opportunities in the global mosquito borne disease market. The development of new diagnostic tools, therapeutic drugs, and vaccines offers potential growth prospects. Moreover, collaborations and partnerships between pharmaceutical companies, research institutions, and governments are likely to accelerate the development of innovative solutions for mosquito control and prevention.

Key features of the study:

This report provides in-depth analysis of the global mosquito borne disease market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global mosquito borne disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson, Eisai Co., Ltd, Takeda Pharmaceutical Company Limited, AstraZeneca, Valeant Pharmaceuticals International, Inc., Mitsubishi Tanabe Pharma Corporation, Abbott , F. Hoffmann-La Roche Ltd, Sun Pharmaceutical Industries Ltd, Lupin Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Serum Institute of India Pvt. Ltd., CSL Limited, and Teva Pharmaceutical Industries Ltd
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global mosquito borne disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mosquito borne disease market

Mosquito Borne Disease Market Detailed Segmentation:

By Disease Type:
- Malaria
- Dengue
- Yellow Fever
- West Nile Virus
- Chikungunya
- Zika Virus
- Others
By Treatment Type:
- Medication
- Vaccination
- Vector Control Methods
- Immunotherapy
- Supportive Care
- Others
By End User:
- Hospitals
- Clinics
- Diagnostic Centers
- Research Institutes
- Government Organizations
- NGOs
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- GlaxoSmithKline plc
- Sanofi S.A.
- Pfizer Inc.
- Merck & Co., Inc.
- Novartis AG
- Johnson & Johnson
- Eisai Co., Ltd
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- Valeant Pharmaceuticals International, Inc.
- Mitsubishi Tanabe Pharma Corporation
- Abbott
- F.Hoffmann-La Roche Ltd
- Sun Pharmaceutical Industries Ltd
- Lupin Pharmaceuticals, Inc.
- BioCryst Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Serum Institute of India Pvt. Ltd.
- CSL Limited
- Teva Pharmaceutical Industries Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Mosquito Borne Disease, By Disease Type
- Market Mosquito Borne Disease, By Treatment Type
- Market Mosquito Borne Disease, By End User
- Market Mosquito Borne Disease, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Mosquito Borne Disease Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Mosquito Borne Disease Market, By Disease Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Malaria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Dengue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Yellow Fever
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
West Nile Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Chikungunya
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Zika Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Mosquito Borne Disease Market, By Treatment Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Vaccination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Vector Control Methods
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bin)
Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Supportive Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Mosquito Borne Disease Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Government Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
NGOs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Mosquito Borne Disease Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eisai Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Valeant Pharmaceuticals International, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mitsubishi Tanabe Pharma Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sun Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lupin Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BioCryst Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Serum Institute of India Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
CSL Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

FAQ

蚊媒感染疾病市场按疾病类型、治疗类型、最终用户和地区划分

Mosquito Borne Disease Market, By Disease Type, By Treatment Type, By End User, By Geography

市场动态：

本研究的主要特点

目录

第一章调查目的与前提条件

第二章市场展望

第三章市场动态、法规与趋势分析

4. 全球蚊媒感染疾病市场-冠状病毒（COVID-19）大流行的影响

5. 2020-2032 年全球蚊媒感染疾病市场（依疾病类型）

6. 2020-2032 年全球蚊媒感染疾病市场（依治疗类型）

7. 2020 年至 2032 年全球蚊媒感染疾病市场（依最终使用者划分）

8. 2020-2032 年全球蚊媒感染疾病市场（按地区）

第九章竞争态势

第 10 章章节

Market Dynamics:

Key features of the study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Mosquito Borne Disease Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Mosquito Borne Disease Market, By Disease Type, 2020-2032, (US$ Bn)

6. Global Mosquito Borne Disease Market, By Treatment Type, 2020-2032, (US$ Bn)

7. Global Mosquito Borne Disease Market, By End User, 2020-2032, (US$ Bn)

8. Global Mosquito Borne Disease Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

蚊媒感染疾病市场按疾病类型、治疗类型、最终用户和地区划分

Mosquito Borne Disease Market, By Disease Type, By Treatment Type, By End User, By Geography

市场动态：

本研究的主要特点

目录

第一章 调查目的与前提条件

第二章 市场展望

第三章市场动态、法规与趋势分析

4. 全球蚊媒感染疾病市场-冠状病毒（COVID-19）大流行的影响

5. 2020-2032 年全球蚊媒感染疾病市场（依疾病类型）

6. 2020-2032 年全球蚊媒感染疾病市场（依治疗类型）

7. 2020 年至 2032 年全球蚊媒感染疾病市场（依最终使用者划分）

8. 2020-2032 年全球蚊媒感染疾病市场（按地区）

第九章 竞争态势

第 10 章 章节

Market Dynamics:

Key features of the study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Mosquito Borne Disease Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Mosquito Borne Disease Market, By Disease Type, 2020-2032, (US$ Bn)

6. Global Mosquito Borne Disease Market, By Treatment Type, 2020-2032, (US$ Bn)

7. Global Mosquito Borne Disease Market, By End User, 2020-2032, (US$ Bn)

8. Global Mosquito Borne Disease Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

第一章调查目的与前提条件

第二章市场展望

第九章竞争态势

第 10 章章节